Oral Presentation 8th Australasian Virology Society Meeting and 11th Annual Meeting of the Australian Centre for Hepatitis & HIV Virology Meeting 2015

Investigating the Repertoire of Immune Subsets that Encounter Viruses in Human Anogenital Tissues (#48)

Rachel A Botting 1 2 , Kirstie M Bertram 1 2 , Heeva Baharlou 1 2 , Min Kim 1 , Kerrie Sandgren 1 , Anthony L Cunningham 1 2 , Andrew N Harman 1
  1. Westmead Millennium Institute, Westmead, NSW, Australia
  2. University of Sydney, Sydney, NSW, Australia

Human anogenital mucosae contain various tissue types, which represent unique opportunities and barriers for transmission of viruses, and each of these tissues should be considered separately in terms of how transmission occurs. Dendritic cells (DCs) and macrophages present in these tissues are two of the first cell types to encounter viruses during sexual intercourse. Furthermore, these cells play a direct role in the transmission of some viruses such as HIV where they transfer the virus to T cells in which explosive replication occurs.

Different anogenital tissues are likely to contain unique combinations of DC and macrophage subsets, which is likely modulated by the unique cytokine environment of each tissue. Although DC subsets found within squamous epithelium and dermis at non-mucosal sites are well characterised, very little human data is available concerning differences between DC subsets in different anogenital tissues, particularly lamina propria DC subsets in the rectum and anus.

Therefore, we have gained access to all the anogenital tissues that HIV encounters during transmission (labia, vagina, cervix, glans penis, foreskin, anus and rectum). Using flow cytometry and florescence microscopy we have thoroughly characterised the immune populations found in these tissues. Critically, we have identified key differences in specific immune cell subsets present in different anogenital sites and in the viral binding receptors they express.

Understanding the differences in composition of immune cells that interact with viruses in anogenital tissues is critical in the development of strategies to block transmission and in mucosal vaccine development. This is particularly the case for anorectal tissue as there is little knowledge available on its immune cell composition. This represents a key gap in our understanding as transmission across this tissue is hundreds of times more efficient in the case of HIV and there is a growing prevalence in Human Papilloma Virus associated anal cancer.